Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001437749-26-001670·Stablecoin Development Corp
Schedule 13D ownership disclosure
NovaBay Pharmaceuticals Inc
Common Stock, $0.01 par value · CUSIP: 66987P409
Event date: 2026-01-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- R01 Fund LPReported CIK 0001990517
Shares: 56,806,080.00 · Class: 45.0%
- R01 Capital LLCReported CIK 0002091715
Shares: 56,806,080.00 · Class: 45.0%
- R01 Capital Manager LLCReported CIK 0002091724
Shares: 56,806,080.00 · Class: 45.0%
- Kazley Michael JohnReported CIK 0002091727
Shares: 56,806,080.00 · Class: 45.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-26-001670
- Form type
- SCHEDULE 13D/A
- Filer
- Stablecoin Development Corp
- CIK
- CIK 1389545
- Filed
- Jan 21, 2026
- Reporting period
- Jan 16, 2026
- Description
- Schedule 13D beneficial ownership